Invention Grant
- Patent Title: Glucagon derivatives
-
Application No.: US17499222Application Date: 2021-10-12
-
Publication No.: US12018060B2Publication Date: 2024-06-25
- Inventor: Sung Youb Jung , Young Jin Park , Jong Suk Lee , Jae Hyuk Choi , Chang Ki Lim , Se Chang Kwon
- Applicant: HANMI PHARM CO., LTD.
- Applicant Address: KR Gyeonggi-do
- Assignee: Hanmi Pharm Co., Ltd.
- Current Assignee: Hanmi Pharm Co., Ltd.
- Current Assignee Address: KR Gyeonggi-Do
- Agency: BakerHostetler
- Priority: KR 20140193691 2014.12.30
- The original application number of the division: US16684110 2019.11.14
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61K45/06 ; C07K14/605 ; A61K38/00
Abstract:
The present invention relates to a novel peptide of a glucagon derivative and a composition for preventing or treating obesity comprising the peptide as an active ingredient. The glucagon derivative according to the present invention shows a more excellent activating effect with regard to both glucagon-like peptide-1 receptors and glucagon receptors compared to native glucagon, and thus can be widely used as an effective agent for treating obesity.
Public/Granted literature
- US20220025012A1 GLUCAGON DERIVATIVES Public/Granted day:2022-01-27
Information query
IPC分类:
